Showing 4,861 - 4,880 results of 27,423 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((teer decrease) OR (nn decrease)) ))', query time: 0.93s Refine Results
  1. 4861
  2. 4862

    Identification of +TIPs required for MT plus-end targeting of dynein-dynactin in the <i>C</i>. <i>elegans</i> early embryo. by Daniel J. Barbosa (4288462)

    Published 2017
    “…<b>(C)</b> Cortical confocal section in one-cell embryos co-expressing GFP::p50<sup>DNC-2</sup> and EBP-2::mKate2, showing that depletion of dynein intermediate chain<sup>DYCI-1</sup> or LIS-1 decreases dynactin levels at MT plus ends. …”
  3. 4863
  4. 4864
  5. 4865
  6. 4866

    The percentage of cells with protein aggregates cotransfected with αA- and αB-crystallin or R120G αB-crystallin (αBM) genes by Bing-Fen Liu (81305)

    Published 2011
    “…</p><p></p> The x-axis labels are either RED-αB- or the pairs of GFP-αA- and RED-αB-crystallin. A four-fold decrease of cells with protein aggregates was observed for cotransfection of αA- and αB-crystallin (the asterisk indicates a p=0.006), but only about a 1.5 fold decrease for cotransfection of αA- and αBM-crystallin (the double asterisk indicates a p=0.02). …”
  7. 4867

    Disorder–Order Structural Transformation in Electron-Poor Sr<sub>3</sub>Au<sub>8</sub>Sn<sub>3</sub> Driven by Chemical Bonding Optimization by Qisheng Lin (1680814)

    Published 2013
    “…Single-crystal X-ray diffraction analyses revealed that Sr<sub>3</sub>Au<sub>8</sub>Sn<sub>3</sub> has a La<sub>3</sub>Al<sub>11</sub>-type <i>Immm</i> structure (<i>a</i> = 4.6767(8) Å, <i>b</i> = 9.646(2) Å, <i>c</i> = 14.170(2) Å, <i>Z</i> = 2) if annealed at 550 °C and above but a Ca<sub>3</sub>Au<sub>8</sub>Ge<sub>3</sub>-type structure (<i>Pnnm</i>, <i>a</i> = 9.6082(8) Å, <i>b</i> = 14.171(1) Å, <i>c</i> = 4.6719(4) Å, <i>Z</i> = 2) if annealed at 400 °C. …”
  8. 4868

    Engineering of p150<sup>DNC-1</sup> mutants for functional characterization of dynactin's MT binding activity. by Daniel J. Barbosa (4288462)

    Published 2017
    “…<p><b>(A)</b> Cartoon of the dynactin complex and its interaction with MTs and end-binding protein (EB). …”
  9. 4869
  10. 4870
  11. 4871
  12. 4872

    Bmi1 Essentially Mediates Podocalyxin-Enhanced Cisplatin Chemoresistance in Oral Tongue Squamous Cell Carcinoma by Yueying Zhou (450705)

    Published 2015
    “…On the other hand, knockdown of PODXL significantly decreased the Bmi1 expression level and cisplatin IC50 and increased cisplatin-induced cell apoptosis, which was completely reversed by overexpression of Bmi1. …”
  13. 4873

    Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach by P., Sneha

    Published 2017
    “…Maturity-onset diabetes of the young type 3 (MODY3) is a non-ketotic form of diabetes associated with poor insulin secretion. …”
    Get full text
    Get full text
  14. 4874

    The C-terminal tyrosine of α-tubulin is required for centration/rotation of the nucleus-centrosome complex but not for MT tip tracking of dynactin. by Daniel J. Barbosa (4288462)

    Published 2017
    “…<b>(I)</b> <i>(left)</i> Cortical confocal section of a control and <i>tba-1/2(YA/YA)</i> one-cell embryo in metaphase expressing GFP::p50<sup>DNC-2</sup>. …”
  15. 4875

    Morphological schematic diagram of <i>A</i>. <i>Adenophora</i>. by Haojun Li (11007721)

    Published 2024
    “…The phytochemical variability of the extracts was also studied. The LC<sub>50</sub> value of the <i>A</i>. <i>adenophora</i> extract against <i>L</i>. …”
  16. 4876
  17. 4877
  18. 4878

    Monodispersed Sirolimus-Loaded PLGA Microspheres with a Controlled Degree of Drug–Polymer Phase Separation for Drug-Coated Implantable Medical Devices and Subcutaneous Injection by Zilin Zhang (4370773)

    Published 2022
    “…By increasing the drug loading from 33 to 50 wt %, the particle morphology evolved from homogeneous microspheres, in which the drug and polymer were perfectly mixed, to patchy particles, with amorphous drug patches embedded within a polymer matrix to anisotropic patchy Janus particles. …”
  19. 4879

    Monodispersed Sirolimus-Loaded PLGA Microspheres with a Controlled Degree of Drug–Polymer Phase Separation for Drug-Coated Implantable Medical Devices and Subcutaneous Injection by Zilin Zhang (4370773)

    Published 2022
    “…By increasing the drug loading from 33 to 50 wt %, the particle morphology evolved from homogeneous microspheres, in which the drug and polymer were perfectly mixed, to patchy particles, with amorphous drug patches embedded within a polymer matrix to anisotropic patchy Janus particles. …”
  20. 4880